Renewed interest in the potential benefits of psychedelic treatments has led to an upsurge in research. Is the first FDA approval of a psychedelic for therapeutic use on the horizon?
On this episode, Epstein Becker Green...more
This Diagnosing Health Care episode looks at the adjustments to business operations and compliance programs that pharmaceutical and medical device companies need to consider as they launch new products during the ongoing...more
9/29/2020
/ Clinical Trials ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Life Sciences ,
Manufacturer Liability ,
Medical Devices ,
Medical Supplies ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Product Development Protocols ,
Research and Development